RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/20956979http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/20956979http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/20956979http://www.w3.org/2000/01/rdf-schema#comment"Dysbindin-1 regulates D2-receptor trafficking and is implicated in schizophrenia and related cognitive abnormalities, but whether this molecular effect mediates the clinical manifestations of the disorder is unknown. We explored in dysbindin-1-deficient mice (dys-/-) (1) schizophrenia-related behaviors, (2) molecular and electrophysiological changes in medial prefrontal cortex (mPFC) and (3) the dependence of these on D2-receptor stimulation. Dysbindin-1 disruption altered dopamine-related behaviors and impaired working memory under challenging/stressful conditions. Dys-/-pyramidal neurons in mPFC layers II/III were hyperexcitable at baseline but hypoexcitable following D2 stimulation. Dys-/-were also respectively more and less sensitive to D2 agonist- and antagonist-induced behavioral effects. Dys-/-had reduced expression of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) and CaMKKβ in mPFC. Chronic D2 agonist treatment reproduced these changes in protein expression, and some of the dys-/-behavioral effects. These results elucidate dysbindin's modulation of D2-related behavior, cortical activity and mPFC CaMK components, implicating cellular and molecular mechanisms of the association of dysbindin with psychosis."xsd:string
http://purl.uniprot.org/citations/20956979http://purl.org/dc/terms/identifier"doi:10.1038/mp.2010.106"xsd:string
http://purl.uniprot.org/citations/20956979http://purl.org/dc/terms/identifier"doi:10.1038/mp.2010.106"xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/author"Chen J."xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/author"Chen J."xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/author"Yang F."xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/author"Yang F."xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/author"Lu B."xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/author"Lu B."xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/author"Garcia S."xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/author"Garcia S."xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/author"Papaleo F."xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/author"Papaleo F."xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/author"Weinberger D.R."xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/author"Weinberger D.R."xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/author"Crawley J.N."xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/author"Crawley J.N."xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/date"2012"xsd:gYear
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/date"2012"xsd:gYear
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/name"Mol. Psychiatry"xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/name"Mol. Psychiatry"xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/pages"85-98"xsd:string
http://purl.uniprot.org/citations/20956979http://purl.uniprot.org/core/pages"85-98"xsd:string